EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Tackling cutaneous herpes simplex virus disease with topical immunomodulators—a call to action

Luisa F Duarte iD, Javier Carbone-Schellman iD, Susan M Bueno iD, Alexis M Kalergis iD, Claudia A Riedel iD, Pablo A González iD

Clinical Microbiology Reviews · 2025

DOI: 10.1128/cmr.00147-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, 2025. Verfasst von Luisa F Duarte und 5 weiteren Autor:innen. Beteiligte Einrichtung: Millennium Institute on Immunology and Immunotherapy, Santiago, Chile. Hauptthemen laut MEDLINE: Herpes Simplex, Immunomodulating Agents, Immunologic Factors, Simplexvirus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Agencia Nacional de Investigación y Desarrollo (ANID), Millenium Institute of Immunology and Immunotherapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antivirals play important roles in restricting viral diseases. Nevertheless, they act on a relatively limited number of viruses and occasionally display partial effectiveness in some tissues or against escape variants. Although vaccination remains the most cost-effective approach for preventing microbial diseases, developing prophylactic or therapeutic solutions for pathogens, such as herpes simplex viruses (HSVs), that effectively reduce their clinical manifestations in the skin has proven exceptionally challenging despite extensive research. Alternatively, a less explored approach for tackling HSV skin infection involves using topical immunomodulatory molecules to potentiate the host’s innate antiviral immune responses. When applied directly to herpetic skin lesions where viral antigen is present, this strategy has the potential to elicit virus-specific adaptive immunity. Based on currently available data, we foresee substantial potential for this approach in addressing HSV skin infections, along with additional prospects to advance understanding of skin biology and apply relevant new findings to other dermatological conditions. However, due to the limited number of case studies evaluating this method and its safety profile, particularly in immunocompromised individuals and pregnant women, further research is crucial, especially to assess the effects of immunomodulators in these vulnerable populations. Here, we revisit and discuss the use of immunomodulatory molecules for potentiating the host immune response against HSV skin infection and call for action for increased research and clinical trials regarding the possible benefits of this latter strategy for treating HSV cutaneous disease and recurrences. We also revisit and discuss antivirals and vaccine candidates against HSVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes SimplexImmunomodulating AgentsImmunologic FactorsSimplexvirusHumansAntiviral AgentsAdministration, TopicalAnimals

Stichwörter der Autor:innen

HSVacyclovirdendritic cellsherpetic skin lesionsherpetic skin recurrencesimmune response modifiersimmunityimmunotherapytherapyvaccine

Substanzen

Immunomodulating AgentsAntiviral AgentsImmunologic Factors

Autor:innen und Institutionen

  • Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
  • Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana - Universidad del Desarrollo, Santiago, Chile.
  • Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Departamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Centro de Investigación para la Resilencia a Pandemias, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.

ORCID-Profile: Luisa F Duarte, Javier Carbone-Schellman, Susan M Bueno, Alexis M Kalergis, Claudia A Riedel, Pablo A González

Förderung

  • Agencia Nacional de Investigación y Desarrollo (ANID)
  • Millenium Institute of Immunology and Immunotherapy

Zitieren

APA

Duarte, L. F., Carbone-Schellman, J., Bueno, S. M., Kalergis, A. M., Riedel, C. A., & González, P. A. (2025). Tackling cutaneous herpes simplex virus disease with topical immunomodulators—a call to action. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00147-24

Vancouver

Duarte LF, Carbone-Schellman J, Bueno SM, Kalergis AM, Riedel CA, González PA. Tackling cutaneous herpes simplex virus disease with topical immunomodulators—a call to action. Clinical Microbiology Reviews. 2025. doi:10.1128/cmr.00147-24

BibTeX
@article{Duarte2025,
  author = {Duarte, Luisa F and Carbone-Schellman, Javier and Bueno, Susan M and Kalergis, Alexis M and Riedel, Claudia A and González, Pablo A},
  title = {Tackling cutaneous herpes simplex virus disease with topical immunomodulators—a call to action},
  journal = {Clinical Microbiology Reviews},
  year = {2025},
  doi = {10.1128/cmr.00147-24}
}
Kostenlos starten →